Annual Report 2020

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 2020 Reckitt Annual Report and Accounts 2020 Reckitt Annual Report and Accounts 2020 BUILDING SHARED SUCCESS Contents Strategic Report 01 Financial highlights 02 At a glance WELCOME 04 Chairman’s statement 06 Chief Executive Officer’s statement 08 Talking to our business leaders 10 Our business model 12 Purpose-led growth 14 Mapping what matters to our stakeholders 16 Our markets and megatrends OUR 18 Delivering our strategy 24 Key performance indicators 28 Our consumers 32 Our customers PURPOSE 36 Our investors We exist to protect, heal and nurture in the 40 Our people relentless pursuit of a cleaner and healthier world. 44 Our partners 48 Our communities 52 Our environment 56 Non-financial information statement 58 s172 statement 62 Operating review: Hygiene OUR 66 Operating review: Health 70 Operating review: Nutrition 74 Group financial review FIGHT 80 Risk management We have a fight on our hands. A fight to make access 93 Viability statement to the highest quality hygiene, wellness and nourishment Governance a right and not a privilege. 94 Board of Directors 99 Group Executive Committee 102 Corporate governance report About our new brand 113 Nomination Committee report 119 Audit Committee report Reckitt branding reflects the purpose, fight, compass and 128 CRSEC Committee report behaviours of the company. Our new identity draws on our rich Directors’ remuneration report 200 year heritage. It symbolises the energy and can-do spirit of 134 our people and the positive impact that they create on the world. 158 Report of the Directors Designed to be accessible, active and authentic; Reckitt is inspired 161 Statement of Directors’ responsibilities by our purpose-led brands, and our efforts for a healthier planet and a fairer society. Financial Statements 162 Independent auditor’s report 174 Financial statements To learn more visit: www.reckitt.com/thisisreckitt 237 Shareholder information PG62 PG66 PG70 Hygiene Health Nutrition STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS Financial highlights Net Revenue Adjusted Operating Margin4 Reported Operating Margin £14.0bn 23.6% 15.4% +11.8% LFL growth4 -260bps nm 3 Reported growth +8.9% Hygiene Health Nutrition 42% 35% 23% of Reckitt Total Net Revenue of Reckitt Total Net Revenue of Reckitt Total Net Revenue Adjusted Earnings Per Share (diluted)4 Reported Earnings Per Share (diluted) Total dividend for the year 327.0 p 159.3p 174.6p -6.3% nm 3 unchanged Society Net Revenue from more Number of people informed through FTSE4Good Index membership sustainable products1, 2, 4 health and hygiene messaging and campaigns since 2013 30.4% 1.41bn 17 consecutive years, including meeting 20 additional Breast-Milk-Substitute (BMS) criteria since 2018 Environment Greenhouse Gas emissions Water use per unit of production1 1. Excluding our Infant and Child Nutrition (IFCN) per unit of production1 business – see Reckitt insights (www.reckitt.com/ responsibility/policies-and-reports) for details 2. Calculated for 12 months ending 30 September 2020 3. Not meaningful 53% 39% 4. Non-GAAP measures are defined on page 77 reduction since 2012 reduction since 2012 Reckitt Annual Report and Accounts 2020 01 AT A GLANCE Our Group is divided into three business units – Hygiene, Health and Nutrition – with each operating across attractive and growing segments. HYGIENE Our portfolio is underpinned by five global Hygiene is the foundation of health and our purpose-led portfolio works megatrends that drive demand for our to eliminate dirt, germs, pests and odours with market leading products such as Lysol, Finish, Mortein and AirWick. products. As a result, we are well positioned to benefit as we recover from COVID-19, and to deliver sustainable mid-single digit growth in the medium to long-term. Hygiene Net Revenue 2020 2019 £5,816m £5,031m LFL Growth1 Actual Growth +19.5% +15.6% Adjusted Operating Profit1 Adjusted Operating Margin1 £1,505m 25.9% Geographic profile Developed markets 79% Developing markets 21% Key Hygiene brands 02 Reckitt Annual Report and Accounts 2020 STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS HEALTH NUTRITION Our Health portfolio brings compelling, innovative solutions that provide The Nutrition business includes our leading infant and child nutrition, pain relief, protection, hygiene, and personal care to households across adult nutrition and our range of vitamins, minerals and supplements. Brands the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, include Airborne, Mead Johnson, Move Free and Schiff. The strength of this Strepsils and Veet. business is its focus on science-led innovations which underpin products catering to consumers from infant through to the elderly. Health Net Revenue Nutrition Net Revenue 2020 2019 2020 2019 £4,890m £4,462m £3,287m £3,353m LFL Growth1 Actual Growth LFL Growth1 Actual Growth +12.1% +9.6% UNCHANGED -2.0% Adjusted Operating Profit1 Adjusted Operating Margin1 Adjusted Operating Profit1 Adjusted Operating Margin1 £1,334m 27.3 % £462m 14.1% Geographic profile Geographic profile Developed markets 54% Developed markets 45% Developing markets 46% Developing markets 55% Key Health brands Key Nutrition brands 1. Non-GAAP measures are defined on page 77 Reckitt Annual Report and Accounts 2020 03 CHAIRMAN’S STATEMENT I am proud of what we were able to achieve this year in the face of some enormous challenges. Reckitt is emerging much stronger, as a more resilient and purposeful company. We made significant progress in 2020 in building the foundations for future growth. We have added exceptional leadership talent at the top of Reckitt and across many of our geographies to help steer the company through this transformational stage. We are investing in capabilities and have organised ourselves to become more focused and purpose-led. Business performance Full year net revenue was £13,993m, with growth of +11.8% on a like-for-like basis. This was underpinned by strong performances from both Hygiene and Health; despite mixed markets, Nutrition also made good operational improvements while separating from Health and integrating Vitamins, Minerals and Supplements. The performance uplift reflected the outstanding way our teams responded to the coronavirus pandemic (COVID-19), meeting the substantially increased demand for some of our brands through sharper execution, expanded capacity and better customer service. Together with our ongoing investment in our digital capabilities, this enabled us to deliver a stronger underlying performance across our portfolio of brands. Adjusted operating profit was £3,301m, at an adjusted operating margin of 23.6%, MOVING down 260bps on last year in line with our guidance and reflecting planned investment across many areas as laid out by Laxman in the strategy presentation in February 2020. Our business made solid progress on many fronts. It is an early indicator that the FORWARD strategy announced last February is gaining momentum and yielding positive results. We remain focused on delivering our strategy. Although it is too soon to be definitive, we believe that much of the additional demand we saw during 2020 for our Hygiene and Health TOGETHER brands is likely to be sustained even after the pandemic. We are accordingly investing in additional capacity and in expanding our Hygiene and disinfection business into new geographies and business segments. For our Nutrition business, we delivered good growth in North America and from our Vitamins, WITH PURPOSE Minerals and Supplements portfolio, although the operating environment in China continues to be challenging for our infant formula products. As a result, Laxman and the team are conducting a strategic review of our infant formula activities in China and we’ll act on the conclusions of this in due course. In the meantime, our focus is on sustaining the wider investments for growth that have already started to yield benefits with renewed innovation, such as our first adult nutrition product, launched in December. Governance and risk management have Chris Sinclair been important areas of focus for the Board Chairman over the last few years. We have done a lot 04 Reckitt Annual Report and Accounts 2020 STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS of work through the Corporate Responsibility, considerable opportunities, but it also posed colleagues worldwide have been able to Sustainability, Ethics and Compliance Committee some major challenges during a global achieve in difficult times. That goes equally to broaden and deepen our approach to pandemic. Our factories, suppliers and logistics for my fellow Directors. The company is very managing safety and compliance risk, and to operations had to contend with social distancing fortunate to have highly talented individuals focus on our sustainability agenda. We continue and quarantine constraints, which were often on the Board who are committed to Reckitt to expand the investments and initiatives imposed at very short notice. This added to the and passionate about its purpose. that enhance the safety and efficacy of our complexity of stepping up supplies. I am proud We welcomed two new Non-Executive products, as well as their sustainability. to say that our people rose to the challenge. Directors this year who are already making Consistent with the expectations we set They responded with flexibility, commitment valuable contributions to our deliberations. out last year, the Directors have proposed and Reckitt’s characteristic, can-do spirit. Margherita Della Valle joined us in July 2020 a final dividend of 101.6 pence per share, These efforts allowed us to scale up our and also became a member of the Audit which when added to the interim dividend product supply dramatically in critical areas. Committee. Margherita has extensive of 73 pence, gives a full-year dividend of We strengthened our global supply chain and experience of financial markets and digital 174.6 pence per share. Subject to shareholder improved customer service levels. We continued technologies and has been instrumental approval at the AGM in May 2021, this will to make good strides in digital and e-commerce in business transformation programmes in be paid on 14 June 2021 to shareholders and are now building a competitive advantage her prior roles.
Recommended publications
  • Acquisition Agreement for Paras Pharmaceuticals -- Current
    Dealdoc Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Reckitt Benckiser Dec 13 2010 © 2009-2021, Wildwood Ventures Ltd. All rights reserved. Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Companies: Reckitt Benckiser Announcement date: Dec 13 2010 Deal value, US$m: 730.0 : acquisition value • Details • Financials • Termsheet • Press Release • Filing Data • Contract Details Announcement date: Dec 13 2010 Pharmaceutical Industry sectors: Consumer health Financials Deal value, US$m: 730.0 : acquisition value Termsheet 13 December 2010 Reckitt Benckiser has agreed to buy Paras forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million). RB will finance the transaction from existing facilities. Press Release RB Buys India’s Paras Pharmaceuticals Ltd 13 December 2010 Reckitt Benckiser Group plc (RB) today announces that it has agreed to buy Paras Pharmaceuticals Limited (Paras) forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million) from the current shareholders, including the Patel family and Actis, the emerging markets private equity investor. RB will finance the transaction from existing facilities. Paras is a privately-owned Indian company with a portfolio of leading Indian over the counter Health and Personal Care brands including: Moov, the No 2 topical analgesic pain ointment, D’Cold, the No 2 cold & flu remedy, Dermicool, the No 2 for prickly heat, Krack, the No 1 medicated skin treatment for cracked heels and Itch Guard and Ring Guard anti fungal creams. In addition, Paras has a personal care business led by Set Wet, a leading hair gel and deodorant brand. In the fiscal year ending March 2010, Paras generated net sales of INR 4,014 million, representing a mid-teens average growth rate over the last four years, and operating EBITDA for the same year of INR 1,083 million (approximately GBP 56 million and GBP 15 million respectively).
    [Show full text]
  • Reckitt Partners with the Cambridge Centre for Risk Studies As It Advances Its Commitments to Carbon Neutrality
    Reckitt partners with the Cambridge Centre for Risk Studies as it advances its commitments to carbon neutrality 9 June 2021 – Reckitt today announces its strategic partnership with the Cambridge Centre for Risk Studies (CCRS) as it progresses its sustainability ambitions. The partnership advances Reckitt’s ongoing commitment to deliver on the Paris Accord and its ambition for carbon neutrality by 2040 while delivering growth and long-term shareholder value. Its strategy for managing climate change includes action across the entire footprint of its organisation. The CCRS is working with Reckitt to support its climate change activity with analytics, including: • A detailed assessment of leading climate science to test and inform activity within changing patterns of extreme weather, and different scenarios of transition risks including regulatory change and consumer sentiment trends. • Strengthening Reckitt’s financial quantification of these impacts, by mapping Reckitt’s global business activities and the potential consequences of future changes. • Analysis of potential ways to evolve the business to achieve its goals for the Paris Accord and net-zero ambitions. Reckitt is the official Hygiene Partner for COP26, and is playing its part in tackling climate change by setting science-based targets to reach net zero emissions. In June 2020, Reckitt committed to accelerate the delivery of the Paris Climate Change Agreement and RE100, with the goal of achieving 100% renewable electricity across its operations by 2030 as part of an ambition to be carbon neutral by 2040. David Croft, Global Director of Sustainability, Reckitt, said: “We selected Cambridge because of its experienced, comprehensive and science-based approach to assessing and addressing climate-related risks, opportunities and metrics.
    [Show full text]
  • RB Partners with Veolia to Drive a Circular Plastics Economy
    RB partners with Veolia to drive a circular plastics economy Reckitt Benckiser (RB) and Veolia have today announced their partnership to drive the shift to a circular plastics economy. The partnership with Veolia is another step RB is taking to fulfil its pledge to make 100 percent of its plastic packaging recyclable and to contain at least 25 percent recycled content by 2025. Veolia and RB started working together two years ago to work on increasing the use of postconsumer recycled plastic in RB’s packaging. The first offering from the partnership is the new packaging for Finish Quantum. The packaging now contains 30% recycled plastic and is proudly grey in colour because RB has decided not to add masking pigments or additives to the packaging. The companies will continue their collaboration on designing for recyclability and the maximization of post-consumer recycled content. To accelerate the circular plastics economy, a team of 20 experts from RB and Veolia are also working to develop enhanced collection systems, driving behaviour change to aid consumer sorting habits and improving recycling from households. “The partnership between Veolia and RB Hygiene Home brings together our complementary capabilities to drive ​ a positive contribution to the circular economy. We have just started the journey by increasing recycled content and improving recyclability and are excited about the wider opportunities across our value chains”, says Fabrice ​ Beaulieu, EVP Marketing, R&D and Sustainability for RB Hygiene Home. “We are delighted to be collaborating with RB on this ongoing strategy to reduce their environmental footprint. ​ We are working hand-in-hand with RB to develop packaging with greater recycled content and improved recyclability for the RB group’s consumers,” says Antoine Frérot, Chairman and CEO of Veolia.
    [Show full text]
  • COVID-19 Public Policy Group Report April 25, 2020
    COVID-19 Public Policy Group Report April 25, 2020 President Donald Trump on Friday signed the US$484 Tax and Economic Development Updates billion Paycheck Protection Program and Health Care Enhancement Act into law, triggering a joint announcement With the interim PPP funding bill now signed into law, the by the U.S. Department of the Treasury and Small Business SBA and Treasury Department have indicated that applications Administration (SBA) that the CARES Act‘s Paycheck will be accepted again beginning at 10:30am on Monday, April Protection Program (PPP) will resume operations Monday 27. In a joint statement, Treasury Secretary Mnuchin and SBA morning at 10:30am EST. Meanwhile, details continued to Administrator Jovita Carranza noted: “The PPP has supported trickle out about the respective agendas of the White House more than 1.66 million small businesses and protected and Democratic congressional leadership for negotiations over 30 million jobs for hardworking Americans…With the over the next federal COVID-19 response measure. additional funds appropriated by Congress, tens of millions of additional workers will benefit from this critical relief.” The House Speaker Nancy Pelosi (D-CA) and her lieutenants will two also made clear that the SBA “has properly coded the have the pen in writing the first iteration of the next pandemic system to account for changes,” including the US$60 billion response bill, which House Majority Leader Steny Hoyer (D- set aside for smaller financial institutions. Additionally, the MD) has indicated will be unveiled by May 4. SBA yesterday published additional PPP guidance regarding Congressional Democrats are reportedly eyeing the inclusion requirements for promissory notes, authorizations, affiliation, of another round of direct “stimulus” cash payments to and eligibility.
    [Show full text]
  • Product & Price# of Barcodes
    Product & Price# of Barcodes <span class="hilite">Cleaning</span> Air Wick Freshmatic Ultra1 Starter Kit (2 gadgets + 2 refills) - $12.99 Air Wick Freshmatic Ultra4 Refill (4 pack/6.17 oz) - $13.99 Air Wick Scented Oils1 (1 warmer + 7 refills) - $11.99 Air Wick Scented Oils1 Refill (8 pack) - $12.99 Air Wick Candles (twin2 pack) - $9.99 Clorox Foaming Bathroom3 Cleaner (3 pack/30 oz) - $8.49 Clorox Toilet Wand (361 ct refill with bonus wand) - $16.49 Clorox Automatic Toilet1 Bowl Cleaner (6 ct/3.5 oz) - $10.79 Clorox Disinfecting Wipes1 (5 pack/78 ct) - $14.99 Clorox Green Works Natural2 Cleaner (twin pack) - $4.99 Clorox Oxi Magic (7.81 lbs) - $9.99 Clorox Clean Up (1802 oz + 32 oz trigger) - $10.49 Clorox Pool & Spa Shock1 Plus, 12 pk./1 lb. $34.99 Clorox Pool & Spa Algaecide and Clarifier, 2 pk./1 gal. $14.99 Clorox Pump 'n Clean (2 pumps + 2 refills/18 oz) - $9.99 Clorox Bleach (2/182 2oz bottles) - $5.99 Damp Rid Moisture 46 Pack Hanging - $9.99 DampRid Buckets (6 pack)1 - $9.99 Fabuloso All Purpose 3Cleaner (169 oz) - $7.99 Febreze Air Effects (32 pack/9.7 oz) - $6.99 Febreze Air Effects Heavy1 Duty Crisp Clean Air Freshener (twin pack/19.4 oz) - $5.99 Febreze Set and Refresh2 (2 ct) - $7.99 Febreze Fabric 2 ct. 541 oz. - $7.99 Febreze Car Vent Clips3 (4 ct) $8.99 Febreze Unstopables2 (3 pack/8.8 oz) 8.99 Formula 409 (180 oz 1+ 32 oz) - $11.99 Glade PlugIns (2 warmers1 + 6 refills) - $11.49 Glade PlugIns (8 pack2 refill) - $12.99 Kaboom (twin pack/403 oz) - $8.79 Liquid Plumbr Foam Pipesnake2 (3 pack/17 oz) - $8.99 Liquid Plumbr ProStrength3 (twin pack/80 oz) - $9.99 Lysol Neutra Air (3 pack/164 oz) - $9.99 Lysol Neutra Air Sanitizing4 Spray, 3 pk./16 oz.
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • RB Acquires Queen V
    RB Acquires Queen V An insurgent consumer loved brand in $7Bln+ female intimate hygiene category, re- enforcing commitment to Sexual Wellbeing growth, de-stigmatization and development. London, January 20, 2021 – RB today announces that it has acquired Queen V, a feminine wellness brand established in the US, focused on vaginal health. Founded in 2018 in California, Queen V takes a unique and inclusive approach to vaginal health with its commitment to make feminine wellness more accessible and empower women to take control of their bodies. The acquisition of the Queen V brand is demonstrative of RB’s commitment to innovative, purpose-driven brands that consumers love and is in line with the strategy to play in new spaces and adjacencies. Queen V will be part of RB’s Health Global Business Unit, alongside leading sexual wellbeing brands, KY and Durex. “Queen V is a fantastic purpose-driven brand with products that appeal to the needs of our diverse and evolving customer base. This innovative brand has the potential to enhance wellness and make a positive difference to many consumers’ daily lives. Working together with the Queen V team, we are committed to the shared mission of de-stigmatization, focusing on women’s needs and vagina-positivity” said Olga Osminkina-Jones, Global Senior Vice President of Sexual Wellbeing at RB. For further information, please contact: [email protected] / [email protected] About RB RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.
    [Show full text]
  • ON TRACK for FULL-YEAR TARGETS Q1 2019 Trading Update
    02 May 2019 ON TRACK FOR FULL-YEAR TARGETS Q1 2019 Trading Update Q1 £m LFL1 FX Reported IFCN 758 +5% +3% +8% OTC 470 -9% 0% -9% Other 707 0% +1% +1% Total Health 1,935 0% +1% +1% Hygiene Home 1,222 +3% -1% +2% Total 3,157 +1% 0% +1% Highlights LFL growth in Q1 of +1%. Continuing momentum in Hygiene Home. Slow start in Health as expected. LFL performance in Total Health was flat. Progress in IFCN USA and China was offset by seasonal weakness in OTC and a mixed result from Other (Wellness and Health Hygiene) brands. LFL growth in Hygiene Home of +3%. Continued momentum with strong performances from Finish, Vanish and Harpic. We remain on track for the full year net revenue target of +3-4% LFL with growth to be H2 weighted. RB2.0 remains on track. Commenting on these results, Rakesh Kapoor, Chief Executive Officer, said: “As expected, Q1 saw a slow start to the year, especially in OTC. We expect to see improving growth in the remainder of the year, particularly in H2. Our health business unit (BU) was impacted by the unusually weak cold and flu season across US and several European markets and associated retailer inventory movements. While our seasonal products declined, Nurofen and Gaviscon delivered good growth from a combination of recent innovations and quality base products. Our IFCN business delivered a good Q1 (+5%), with innovation led momentum continuing in the US and further progress in China. E-commerce backed by strong investment, continues to perform well with 10% of net revenue coming from these faster growing channels in our Health BU.
    [Show full text]
  • Sexing Capitalism: Condoms and Industrial Change Peter Chua, San Jose State University
    San Jose State University From the SelectedWorks of Peter Chua August, 2004 Sexing Capitalism: Condoms And Industrial Change Peter Chua, San Jose State University Available at: https://works.bepress.com/peter_chua/17/ Sexing Capitalism: Condoms And Industrial Change Peter Chua Department of Sociology San José State University [email protected] Paper Submitted for the 2003 99th Annual Meeting of the American Sociological Association, San Francisco, CA Sexing Capitalism: Condoms And Industrial Change Abstract In the late 1700s, condoms were luxury items for the affluent in Western Europe, but by the 1970s, the US government gave free condoms out to poor women in Third World areas. Moreover condom availability has increased dramatically since the global emergence of the AIDS pandemic in the 1980s, adding to the already fervent social stigmatization and political contentions on morality, sexuality, and wellbeing that condom use brings. This paper focuses on the strategically joint-relationship between manufacturing firms and governments to foster distinct profit-oriented condom social relations and moral-symbolic regimes of sexual cultures. Proposing a sex-situated theory of capitalist firms, the paper examines the crucial social aspect of condom production, focusing on the changes in the condom manufacturing industry from its initial colonial- “warfare” period (1880s-1930s), its period of massive welfare-state expansion (1940s- 1970s), and its recent neoliberal consolidation (1980s-2000s). Keywords Capitalist Institutions, Sexual Cultures, Condom Commodities; Social Aspects of Production; Economic Neoliberalism Sexing Capitalism: Condoms And Industrial Change In the late 1700s, condoms were luxury items for the affluent in Western Europe, but by the 1970s, the US government gave free condoms out to poor women in Third World areas.
    [Show full text]
  • Elegant Napkins 500Ct 12Pk $22.49 Elegant Tissues 230Ct 24Pk $20.49
    1 2 Elegant Napkins Elegant Tissues 500ct 12pk $22.49 230ct 24pk $20.49 For questions regarding prices on Terms and Conditions large quantity orders, please email $1,000 minimum order for free delivery within the 5 boroughs of NY, or fax us a list of the items you are NJ & PA. interested in along with quantities. Tailgate delivery only. We can order specialty items Freight charge of $75 for orders under minimum. direct from all major Call for rates outside the NJ/NY area. manufacturers. Easy ordering: All sales are COD cash unless arranged in advanced. Phone, Fax, Online or contact your We ship paper products or specials only equal amount of the other sales rep. We appreciate your products. business and look forward to Prices and availability are subject to change. providing you with quality products Unit price is listed for reference only. and excellent customer service. Prices are by the case ONLY. We are not responsible for any typographical errors. Pictures are a representation of product and may not be exactly the same. We reserve the right to limit quantities ordered. 1 2 3 Member's Mark Long Member's Mark Member's Mark Long Pepsi-Cola Can 4 Grain White Rice - 25lb Parboiled Rice Long Grain White Rice - 50lb 12oz/36pk Grain - 25lb Clorox Toilet Bowl Cleaner All Soft Scrub Cleaner All kinds- kinds 24oz/9pk 24oz/12pk $22.49 $21.49 $11.59 $13.49 $19.49 $0.35 $1.79 $2.50 $11.99 $11.59 $13.99 $13.49 $19.99 $19.49 $12.99 $12.59 Pledge Multi-Surface Spray All Gain Ultra Powder Detergent All Pepsi-Cola Bottles Coca Cola Cans
    [Show full text]
  • Durex in India: the Category Normalisation Challenge
    IIMC-CRC-2015-09 IIMC CASE RESEARCH CENTRE (IIMCCRC) PRASHANT MISHRA, TINU JAIN MARCH 2014 DUREX IN INDIA: THE CATEGORY NORMALISATION CHALLENGE THE ORIGIN Reckitt Benckiser, a British multinational consumer goods company, has brands like Dettol (the world's largest-selling antiseptic), Strepsils (the world's largest-selling sore throat medicine), Veet (the world's largest-selling depilatory brand), Air Wick (the world's second- largest-selling air freshener), Calgon, Clearasil, Cillit Bang, Durex, Lysol, and Vanish in its portfolio among many others. The company entered into the contraceptive market acquiring Durex brand globally and had started to run that business since Nov’12. Durex has been making highest quality condoms for nearly 80 years. With over 30% of the global branded condom market, it is the number 1 condom brand in the world. However despite dominant market position globally, the brand has the challenge to change the perception of Indian consumers and channel partners regarding sexual well-being (male contraceptive) to normalise the category and drive growth. The current market share of Durex is around 4%1 in India, a market which is underdeveloped compared to other markets regarding the category size and growth. The brand team acknowledges that there is a lot to be done to make the brand a formidable player in the sexual well-being (male contraceptive) category. A recent study commissioned by the Durex brand marketing team has thrown up some interesting facts about the category dynamics and challenges in marketing condom in India. While pondering over the results, the team was clear about one thing, that to play 1 Source: Brand Marketing Team Survey This case was written by Professor Prashant Mishra and Tinu Jain at the Indian Institute of Management Calcutta.
    [Show full text]
  • Betterbusiness Betterfinancials How We Drive Growth and Outperformance
    Reckitt Benckiser Group plc Annual Report and Financial2015 Statements betterbusiness 2015 Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements We make a difference to people’s lives through a trusted portfolio of brands, across consumer health, hygiene and home. Our vision Our purpose A world where people are To make a difference, by healthier and live better. giving people innovative solutions for healthier lives and happier homes. Our strategy betterbusiness betterfinancials How we drive growth and outperformance Chief Executive’s Review on pages 8–9 bettersociety betterenvironment How we support How we reduce our communities and our environmental develop our people impact Strategic framework on pages 12–13 Contents Strategic Report bettersociety Governance Report 1 Highlights 24 – Workplace 46 Board of Directors 2 At a glance 26 – Communities 50 Executive Committee 4 Chairman’s Statement 26 – Products 52 Chairman’s Statement on 7 Reasons why RB delivers betterenvironment Corporate Governance 8 Chief Executive’s Review 27 – Greenhouse gas emissions 54 Corporate Governance Statement 10 Our unique culture 28 – Water 60 Nomination Committee Report 12 Strategic framework 28 – Waste 61 Audit Committee Report 14 Our market and resources 29 – Sourcing 66 Directors’ Remuneration Report betterfinancials 30 Our operating model 68 Our remuneration at a glance 16 – Our strategy to deliver 32 Our operating model in action 70 Annual Report on Remuneration 17 – Organisation 34 Creating stakeholder value 79 Directors’ Remuneration Policy 19 – Powermarkets 36 Financial Review 85 Report of the Directors 20 – Powerbrands 40 Strategic Risks 88 Directors’ Statement of Responsibilities 22 – Virtuous earnings model Financial Statements 89 Financial Statements Any information contained in the 2015 Annual Report and Financial Statements on the price at which shares or other securities in Reckitt Benckiser Group plc have been bought or sold in the past, or on the yield on such shares or other securities, should not be relied upon as a guide to future performance.
    [Show full text]